日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serotonin receptor 5-HT(2A) as a potential target for HCC immunotherapy.

血清素受体 5-HT(2A) 作为 HCC 免疫治疗的潜在靶点

Tay Rong En, Ho Charmaine Min, Ang Nicholas Da Zhi, Tay Hui Chien, Lopez Daniel Z, Na Qiao Rui, Tan Yi Wen, Koh Ser Mei, Tan Kim Peng, Lee Wendy, Lim Jackwee, Lau Maichan, Toh Han Chong, Rotzschke Olaf, Rénia Laurent

Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms

重新审视CD4(+) T细胞在癌症免疫疗法中的作用——对旧范式的新见解

Tay, Rong En; Richardson, Emma K; Toh, Han Chong

Correction: Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

更正:Hdac3是CD8 T细胞细胞毒性程序的表观遗传抑制剂。

Tay, Rong En; Olawoyin, Olamide; Cejas, Paloma; Xie, Yingtian; Meyer, Clifford A; Ito, Yoshinaga; Weng, Qing Yu; Fisher, David E; Long, Henry W; Brown, Myles; Kim, Hye-Jung; Wucherpfennig, Kai W

A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing

一种主要的染色质调节因子决定了肿瘤细胞对T细胞介导的杀伤作用的抵抗力

Pan, Deng; Kobayashi, Aya; Jiang, Peng; Ferrari de Andrade, Lucas; Tay, Rong En; Luoma, Adrienne M; Tsoucas, Daphne; Qiu, Xintao; Lim, Klothilda; Rao, Prakash; Long, Henry W; Yuan, Guo-Cheng; Doench, John; Brown, Myles; Liu, X Shirley; Wucherpfennig, Kai W

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity

抗体介导的MICA和MICB脱落抑制作用促进NK细胞驱动的肿瘤免疫

Ferrari de Andrade, Lucas; Tay, Rong En; Pan, Deng; Luoma, Adrienne M; Ito, Yoshinaga; Badrinath, Soumya; Tsoucas, Daphne; Franz, Bettina; May, Kenneth F Jr; Harvey, Christopher J; Kobold, Sebastian; Pyrdol, Jason W; Yoon, Charles; Yuan, Guo-Cheng; Hodi, F Stephen; Dranoff, Glenn; Wucherpfennig, Kai W